• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Bausch + Lomb closes $790.6M offering

Bausch + Lomb closes $790.6M offering

June 27, 2025 By Sean Whooley

Bausch + Lomb (1)

Bausch + Lomb (NYSE:BLCO) announced that its subsidiaries closed an upsized offering of $790.6 million (€675 million) in senior notes.

The upsized offering included senior secured floating rate notes due 2031. In addition, the company completed a partial refinancing of its credit agreement. In connection with the refinancing, it entered into a third amendment to its existing credit agreement. This provides for a $2.325 billion term B loan facility maturing in 2031 and an $800 million revolving credit facility maturing in 2030.

Notes in the offering bear interest at the rate of three-month EURIBOR (with a 0% floor) plus 3.875% per year. They reset quarterly with a maturation date set for Jan. 15, 2031. Investors purchased the notes at a price of 99.5% of the principal amount thereof.

The Vaughan, Ontario-based eye care company’s new term B loans have an amortization rate of 1% per annum, with the first installment payable on Sept. 30, 2025.

Bausch + Lomb guarantees the notes and each of its subsidiaries serve as guarantors under the credit agreement. The company plans to use net proceeds to repay in full the outstanding borrowings under its existing revolving credit facility. It also intends to refinance in full the outstanding term A loans due 2027 and term B loans due 2027 while also paying related fees and expenses.

Filed Under: Business/Financial News, Funding Roundup, Optical/Ophthalmic, Vision, Wall Street Beat Tagged With: Bausch + Lomb

More recent news

  • Medtronic hires former Recor CEO to run interventional cardiology group
  • Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker
  • Dexcom CFO to expand into COO role
  • Powerful Medical announces FDA De Novo nod for AI ECG and other extra medtech news
  • XCath Robotics receives FDA breakthrough nod for Iris system

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy